| dc.contributor | Fernández Sarmiento, Jaime | |
| dc.creator | Orozco Marun, Rafael Jose | |
| dc.creator | Fernández Sarmiento, Jaime | |
| dc.creator | Morón Duarte, Lina Sofía | |
| dc.date.accessioned | 2014-08-12T13:19:17Z | |
| dc.date.available | 2014-08-12T13:19:17Z | |
| dc.date.created | 2014-08-12T13:19:17Z | |
| dc.date.issued | 2014 | |
| dc.identifier | http://repository.urosario.edu.co/handle/10336/8784 | |
| dc.identifier | https://doi.org/10.48713/10336_8784 | |
| dc.description.abstract | Introduction: Sepsis is a major cause of morbidity and mortality in the pediatric population worldwide. It is widely known that low cardiac output is one of the main factors associated with mortality in pediatric sepsis. It has been suggested venoarterial pCO2 difference as predictor of myocardial function in patients with sepsis, however, to date no studies in children have been done to asses it. Objective: The aim of this study was to determine the predictive capacity and operational characteristics of venoarterial pCO2 difference as predictor of myocardial dysfunction in pediatric patients with severe sepsis and septic shock. Methods: In order to achieve the objectives of the study, it was performed a prospective study of diagnostic tests. Echocardiogram and venoarterial pCO2 difference were done to each patient, then the operating characteristics of the venoarterial difference of pCO2 were calculated, to determine its usefulness. Results: 71 patients were included. The median venoarterial pCO2 difference was not significantly higher in patients who had cardiac dysfunction on echocardiography compared with those with no dysfunction. A statistically significant relationship of values from 1. 5 to 2. 1 mmHg, as a negative predictor of myocardial dysfunction with a sensitivity of 100% and a specificity of 88% was found. Conclusions: The difference venoarterial pCO2 is not yet a good predictor of myocardial dysfunction in pediatric patients with severe sepsis and septic shock, even when other biomarkers are within normal limits. More clinical essays are requerided | |
| dc.language | spa | |
| dc.publisher | Universidad del Rosario | |
| dc.publisher | Especialización en Cuidado Intensivo Pediátrico | |
| dc.publisher | Facultad de medicina | |
| dc.rights | http://creativecommons.org/licenses/by-nc-nd/2.5/co/ | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.rights | Abierto (Texto Completo) | |
| dc.rights | Atribución-NoComercial-SinDerivadas 2.5 Colombia | |
| dc.rights | EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma.
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe.
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización.
--------------------------------------
POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos. | |
| dc.source | 1. Moloney-Harmon P. Pediatric Sepsis: The Infection unto Death. Crit Care Nurs Clin N Am 2005; 17: 417 – 429 | |
| dc.source | 2. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker M, Jaeschke R, Reinhart K, Angus DC, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Crit Care Med 2008; 36:296–327. | |
| dc.source | 3. Carcillo J. Pediatric septic shock and multiple organ failure. Crit Care Clin 2003; 19, 413– 440. | |
| dc.source | 4. Pediatric Advanced Life Support. Provider Manual. American Heart Association. 2006. | |
| dc.source | 5. Vincent JL. Intensive Care Medicine Annual Update. Springer. 2009. | |
| dc.source | 6. West J. B. Best y Taylor. Bases Fisiológicas de la Práctica Médica. 12da Edición. Editorial Médica Panamericana. 1991 | |
| dc.source | 7. Gutierreza G, Wulf-Gutierrez M, Reines D. Monitoring oxygen transport and tissue oxygenation. Curr Opin Anaesthesiol 2004; 17:107–117. | |
| dc.source | 8. Pinsky M. Hemodynamic monitoring in the intensive care unit. Clin Chest Med 2003; 24, 549– 560. | |
| dc.source | 9. Goldstein B, Giroir B, Randolph A and the Members of the International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6:2–8. | |
| dc.source | 10. Valle´e F, Vallet B, Mathe O, Parraguette J, Mari A, Silva S, et al. Central venous-to-arterial carbon dioxide difference: an additional target for goal-directed therapy in septic shock? Intensive Care Med 2008; 34:2218–2225 | |
| dc.source | 11. Durkin R, Gergits MA, Reed JF 3rd, Fitzgibbons J. The Relationship Between the Arteriovenous Carbon Dioxide Gradient and Cardiac Index. J Crit Care. 1993, 8(4):217-21 | |
| dc.source | 12. Ho KM, Harding R, Chamberlain. A comparison of central venous-arterial and mixed venous-arterial carbon dioxide tension gradient in circulatory failure. J.Anaesth Intensive Care. 2007; (5):695-701. | |
| dc.source | 13. Furqan M, Hashmat F, Amanullah M, Khan M, Durani HK, Anwar-ul-Haque. Venoarterial PCO2 difference: a marker of postoperative cardiac output in children with congenital heart disease. J Coll Physicians Surg Pak. 2009; 19(10):640-3. | |
| dc.source | 14. Carcillo J, Han K, Lin J, MD, Orr R. Goal-Directed Management of Pediatric Shock in the Emergency Department. Clin Ped Emerg Med 2007; (8)165-175. | |
| dc.source | 15. Ortegón L, Fernández J. Impacto de la antibioticoterapia empirica temprana en pacientes pediatricos con sepsis en la unidad de cuidado intensivo pediátrico de la Fundación Cardioinfantil. (Tesis de grado). Premio Arturo Aparicio al mejor trabajo de investigación. Universidad del Rosario; 2009. | |
| dc.source | 16. Cuschieri J, Rivers E, Donnino M, Katilius M, Jacobsen G, Nguyen HB, Pamukov N, Horst NM. Central venous-arterial carbon dioxide difference as an indicator of cardiac index. Intensive Care Med 2005; (31) 818–822. | |
| dc.source | 17. Bakker J, Vincent JL, Gris P, Leon M, Goffernils M, Kahn R. Veno –arterial Carbon Dioxide Gradient in Human Septic SOC. Chest 1992; (101) 509 – 15. | |
| dc.source | 18. Nichols, D. Roger's Textbook of Pediatric Intensive Care, 4th Edition. Lippincott Williams & Wilkins. 2008 | |
| dc.source | 19. Troskot R, Šimurina T, Žižak M, Majstorović K, Marinac I, Mrakovčić-Šutić I. Prognostic Value of Venoarterial Carbon Dioxide Gradient in Patients with Severe Sepsis and Septic Shock. Croat Med J. 2010; 51(6):501-8 | |
| dc.source | 20. Futiere E, Robin E, Jabaudon M, Guerin R, Petit A, Bazin JE, Constantin JM, Vallet B. Central venous O2 saturation and venous-to arterial CO2 difference as complementary tools for goal-directed therapy during high-risk surgery. Critical Care 2010; 14 (5):R193 | |
| dc.source | 21. Silva JM, Ribas A, Lopes J, Ribeiro MH, Nacevicius C, Toledo D, Rezende E, Malbouisson L. A large Venous-Arterial PCO2 Is Associated with Poor Outcomes in Surgical Patients. Anesthesiol Res Pract. 2011;2011:759792 | |
| dc.source | 22. Brierley J, Choong K, Cornell T, DeCaen A, Deymann A, Doctor A, Davis A, Duff J, et al. 2007 American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock. Crit Care Med 2009; 37:000–000 | |
| dc.source | 23. Casserly B, Read R, Levy M. Hemodynamic Monitoring in Sepsis. Crit Care Clin 2009; 25 : 803–823 | |
| dc.source | 24. Ruiz A, Morillo L. Epidemiología Clínica. Investigación Clínica Aplicada. Editorial Médica Panamericana. 2004 | |
| dc.source | 25. Allen, Hugh D.; Driscoll, David J.; Shaddy, Robert E.; Feltes, Timothy F. Moss and Adam’s Heart Disease in Infants, Children and Adolescents: Including the fetus and Young Adults. 7th Ed. Lippincott Williams & Wilkins. 2008 | |
| dc.source | 26. Rivers E, Guyen R, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early Goal-Directed Therapy In The Treatment Of Severe Sepsis And Septic Shock. N Engl J Med 2001;345:1368-77 | |
| dc.source | 27. Maddirala S, Khan A. Optimizing Hemodynamic Support in Septic Shock Using Centraland Mixed Venous Oxygen Saturation. Crit Care Clin 2010; 26: 323–333 | |
| dc.source | 28. Rivers EP, Ander DS, Powell D. Central venous oxygen saturation monitoring in the critically ill patient. Curr Opin Crit Care 2001; 7(3):204-11 | |
| dc.source | instname:Universidad del Rosario | |
| dc.source | reponame:Repositorio Institucional EdocUR | |
| dc.subject | Sepsis | |
| dc.subject | Cardiomiopatía | |
| dc.subject | Diferencia venoarterial de pCO2 | |
| dc.subject | Disfunción miocárdica | |
| dc.title | Diferencia venoarterial de Pco2 como predictor de disfunción miocárdica en niños con sepsis severa y choque séptico. | |
| dc.type | masterThesis | |
